Official journal of the Slovak Society of Cardiology,
Slovak Society of Hypertension and Slovak Association for Cardiac Arrhythmias

Cardiology Letters 2018, 27(2):87-93

Gonadal status in males with acute coronary syndrome and the extent of coronary artery disease: a comparative cross-sectional analysis

Bednarova A1, Koller T1, Kuzma M1, Cenkerova K2, Malacky T2, Payer J1
1 Comenius University Faculty of Medicine, 5th Department of Internal Medicine, University Hospital Bratislava
2 Department of Cardiology, National Institute of Cardiovascular Diseases, Bratislava, Slovak Republic

Introduction and aims: Association between coronary artery disease (CAD) and male gonadal status has been previously suggested, but still remains inconclusive. The aims of our study in males with recent acute coronary syndrome (ACS) were to evaluate the prevalence of hypogonadism, to compare their gonadal status with non-ACS matched controls and to evaluate gonadal status by the extent of CAD.

Subjects and methods: A cross-sectional retrospective study included 96 males with recent ACS and age and 49 BMI matched non-ACS controls. Basic demography and standard CAD risk factors were recorded as well as fasting serum levels of total testosterone (TT), sex hormone binding globulin (SHBG), estradiol, follicle-stimulating and luteinizing hormone (FSH and LH) and calculated free androgen index (FAI). First, we evaluated the prevalence of hypogonadism (TT< 7 nmol/l and FAI<24%). Second, we compared patients and control group for ACS associated factors on univariate and multivariate analysis. Third, using the same analysis in patients undergoing coronary angiography we aimed at identifying factors associated with CAD extent (0-1 vessel vs. 2-3 vessel disease).

Results: 96 patients and 49 controls were included. Hypogonadism was confirmed in 20.8% of patients. Patients had lower levels of TT (12.638 ±6.138 vs. 15.702±4.903, p<0.01), FAI (30.292 ±12.489 vs. 36.902 ±9.816, p<0.01) and higher levels of LH (5.58 IQR 4.4-8.21 vs. 5.0 IQR 3.64- 6.35, p=0.04) compared with controls. In multivariate analysis, smoking, hypertension, dyslipidemia and FAI were identified as factors independently associated with ACS. 73 patients underwent coronary angiography, 43 had findings of 2-3 vessel disease. Hypertension, BMI and FAI were found as associated factors with CAD extent and FAI as its single independent risk factor.

Conclusion: Lower gonadal status was found common (20.8%) in males with recent ACS. It was independent on standard ACS risk factors and was independently associated with CAD extent.

Keywords: acute coronary syndrome; testosterone; free androgen index

Published: February 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bednarova A, Koller T, Kuzma M, Cenkerova K, Malacky T, Payer J. Gonadal status in males with acute coronary syndrome and the extent of coronary artery disease: a comparative cross-sectional analysis. Cardiology Letters. 2018;27(2):87-93.
Download citation

References

  1. Pye SR, Huhtaniemi IT, Finn JD, et al., and EMAS Study Group. Late-onset hypogonadism and mortality in aging men. J Clin Endocrinol Metab 2014;99:1357-1366. Go to original source...
  2. Laughlin GA, Barrett-Connor E, Bergstrom J. Low serum testosterone and mortality in older men. J Clin Endocrinol Metab 2008;93:68-75. Go to original source...
  3. Khaw KT, Dowsett M, Folkerd E. Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. Circulation 2007;116:2694-2701. Go to original source...
  4. Vikan T, Schirmer H, Njølstad I, et al. Endogenous sex hormones and the prospective association with cardiovascular disease and mortality in men: the Tromsø Study. Eur J Endocrinol 2009;161:435-442. Go to original source...
  5. Tivesten A, Vandenput L, Labrie F, et al. Low serum testosterone and estradiol predict mortality in elderly men. J Clin Endocrinol Metab 2009;94:2482-2488. Go to original source...
  6. Fernández-Balsells MM, Murad MH, Lane M, et al. Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J Clin Endocrinol Metab 2010;95:2560-2575. Go to original source...
  7. Calof OM, Singh AB, Lee ML, et al. Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. J Gerontol A Biol Sci Med 2005;60:1451-1457. Go to original source...
  8. Vigen R, O'Donnell CI, Barón AE, et al. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA 2013;310:8291836. Go to original source...
  9. Finkle WD, Greenland S, Ridgeway GK, Adams JL, Frasco MA, Cook MB, Fraumeni JF, & Hoover RN. Increased risk of nonfatal myocardial infarction following testosterone therapy prescription in men. PloS One 2014 9 e85805. Go to original source...
  10. Gardner DB, Shoback D. Greenspan's basic and clinical endocrinology. edn 9. The McGraw-Hill Companies, Inc. 2011:395-405.
  11. Freedman J, Glueck CJ, Prince M, et al. Testosterone, thrombophilia, thrombosis. Transl Res. 2015;165:537-548. Go to original source...
  12. Malkin CJ, Pugh PJ, Morris PD, Kerry KE, Jones RD, Jones TH, & Channer KS. Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life. Heart 2004;90:871-876. Go to original source...
  13. English KM, Steeds RP, Jones TH, et al. Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: A randomized, double-blind, placebocontrolled study. Circulation 2000;102:1906-1911. Go to original source...
  14. Webb CM, Elkington AG, Kraidly MM, t al. Effects of oral testosterone treatment on myocardial perfusion and vascular function in men with low plasma testosterone and coronary heart disease. Am J Cardiol 2008;101:618-624. Go to original source...
  15. Foresta C, Zuccarello D, De Toni L, et al. Androgens stimulate endothelial progenitor cells through an androgen receptormediated pathway. Clinical Endocrinology 2008;68:284-289. Go to original source...
  16. Hatakeyama H, Nishizawa M, Nakagawa A, et al. Testosterone inhibits tumor necrosis factor-alpha-induced vascular cell adhesion molecule-1 expression in human aortic endothelial cells. FEBS letters 2002;530:129-132. Go to original source...
  17. D'Agostino P, Milano S, Barbera C, et al. Sex hormones modulate inflammatory mediators produced by macrophages. Ann N Y Acad Sci. 1999;876:426-429. Go to original source...
  18. Page ST, Amory JK, Bowman FD, et al. Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab 2005;90:1502-1510. Go to original source...
  19. Svartberg J, Agledahl I, Figenschau Y, et al. Testosterone treatment in elderly men with subnormal testosterone levels improves body composition and BMD in the hip. Internal Journal of Impotence Research 2008;20:378-387. doi:10.1038/ijir.2008.19 Go to original source...
  20. Srinivas-Shankar U, Roberts SA, Connolly MJ, et al. Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 2010;95:639-650. Go to original source...
  21. Kenny AM, Prestwood KM, Gruman CA, et al. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels. J Gerontol A Biol Sci Med 2001;56:266-272. Go to original source...
  22. Kapoor D, Goodwin E, Channer KS, et al. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol 2006;154:899-906. Go to original source...
  23. Jones TH, Arver S, Behre HM, et al., and TIMES2 Investigators. Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study). Diabetes Care 2011;34:828-837. Go to original source...
  24. Kalinchenko SY, Tishova YA, Mskhalaya GJ, et al. Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study. Clin Endocrinol 2010;73:602-612. Go to original source...
  25. Perusquía M, Stallone JN. Do androgens play a beneficial role in the regulation of vascular tone? Nongenomic vascular effects of testosterone metabolites. Am J Physiol Heart Circ Physiol 2010;298:1301-1307. Go to original source...
  26. English KM, Mandour O, Steeds RP, et al. Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms. Eur Heart J 2000;21:890-894. Go to original source...
  27. Dobrzycki S, Serwatka W, Nadlewski S, et al. An assessment of correlations between endogenous sex hormone levels and the extensiveness of coronary heart disease and the ejection fraction of the left ventricle in males. J Med Invest 2003;50:162-169.
  28. Rosano GMC, Sheiban I, Massaro R, et al. Low testosterone levels are associated with coronary artery disease in male patients with angina. International Journal of Impotence Research 2007;19:176-182. Go to original source...
  29. Malkin CJ, Pugh PJ, Morris PD, et al. Low serum testosterone and increased mortality in men with coronary heart disease. Heart 2010;96:1821-1825. Go to original source...
  30. Barrett-Connor E, Khaw KT. Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study. Circulation 1988;78:539-545. Go to original source...
  31. Arnlöv J, Pencina MJ, Amin S, et al. Endogenous sex hormones and cardiovascular disease incidence in men. Annals of Internal Medicine 2006;145:176-184. Go to original source...
  32. Cauley JA, Gutai JP, Kuller LH, et al. Usefulness of sex steroid hormone levels in predicting coronary artery disease in men. Am J Cardiol 1987;60:771-777. Go to original source...
  33. Phillips GB, Pinkernell BH, Jing TY. The association of hypotestosteronemia with coronary artery disease in men. Arterioscler Thromb Vas Biol. 1994;14:701-706. Go to original source...
  34. Li L, Guo CY, Jia EZ, et al. Testosterone is negatively associated with the severity of coronary atherosclerosis in men. Asian Journal of Andrology 2012;14:875-878. Go to original source...
  35. Ruige JB, Mahmoud AM, De Bacquer D, et al. Endogenous testosterone and cardiovascular disease in healthy men: a metaanalysis. Heart 2011;97:870-875. Go to original source...
  36. Soisson V, Brailly-Tabard S, Helmer C, et al. A J-shaped association between plasma testosterone and risk of ischemic arterial event in elderly men: the French 3C cohort study. Maturitas 2013;75:282-288. Go to original source...
  37. Rastrelli G, Corona G, Lotti F, et al. Relationship of testis size and LH levels with incidence of major adverse cardiovascular events in older men with sexual dysfunction. J Sex Med 2013;10: 761-2773. Go to original source...
  38. Holmboe SA, Vradi E, Jensen TK, et al. The Association of Reproductive Hormone Levels and All-Cause, Cancer, and Cardiovascular Disease Mortality in Men. J Clin Endocrinol Metab 2015;100:4472-4480. Go to original source...
  39. Hyde Z, Norman PE, Flicker L, et al. Elevated LH predicts ischaemic heart disease events in older men: the Health in Men Study. Eur J Endocrinol 2011:164:569-577. Go to original source...
  40. Tengstrand B, Carlström K, Hafström I. Gonadal hormones in men with rheumatoid arthritis-from onset through 2 years. The Journal of Rheumatology 2009;36:887-892. Go to original source...
  41. Spratt DI, Cox P, Orav J, Moloney J, & Bigos T. Reproductive axis suppression in acute illness is related to disease severity. J Clin Endocrinol Metab 1993;76:1548-1554. Go to original source...
  42. Geisthövel W, Perschke B, Mühlen A von zur, et al. (Plasma testosterone, free testosterone fraction LH and FSH in males during the early stage of acute myocardial infarction (author's transl)). Zeitschrift Für Kardiologie 1979;68:776-783.
  43. Rühlmann C, Kellner K, Marek H, et al. Gonadal and adrenocortical hormone changes in myocardial infarct. Zeitschrift Für Die Gesamte Innere Medizin Und Ihre Grenzgebiete 1985;40:505-509.
  44. Hu X, Rui L, Zhu T, et al. Low testosterone level in middle-aged male patients with coronary artery disease. Eur J Intern Med 2011;22:133-136. Go to original source...
  45. Phillips GB, Pinkernell BH, Jing TY. Are major risk factors for myocardial infarction the major predictors of degree of coronary artery disease in men? Metabolism 2004;53: 324-329. Go to original source...
  46. Khazai B, Golden SH, Colangelo LA, et al. Association of endogenous testosterone with subclinical atherosclerosis in men: the multi-ethnic study of atherosclerosis. Clin Endocrinol 2016;84:700-707. Go to original source...
  47. Pesonen E, Pussinen P, Huhtaniemi I. Adaptation to acute coronary syndrome-induced stress with lowering of testosterone: a possible survival factor. Eur J Endocrinol 2016;174:481-489. Go to original source...
  48. Bhasin S, Cunningham GR, Hayes FJ, at al., and Task Force, Endocrine Society. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010;95:2536-2559. Go to original source...
  49. Chubb SAP, Hyde Z, Almeida OP, Flicker L, Norman PE, Jamrozik K, Hankey GJ, & Yeap BB. Lower sex hormone-binding globulin is more strongly associated with metabolic syndrome than lower total testosterone in older men: the Health in Men Study. Eur J Endocrinol 2008;158: 85-792. Go to original source...
  50. Laaksonen DE, Niskanen L, Punnonen K, et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 2004;27:1036-1041. Go to original source...